GlobeNewswire
Groundworks 2026 Puts the Business of Construction Robotics Centre Stage in London
London summit brings construction decision-makers, robotics companies and investors together to tackle the barriers to deploying robots on siteLONDON,...
Euro Stablecoins Added $263 Million in a Year, Up 54%, While Dollar Supply Fell
Banks already issue 29% of euro stablecoins and 98% of supply is MiCA-licensed, DIA’s study of 140+ stablecoins in 25 currencies showsZug, Switzerland...
Greif Named Top 100 Most Loved Workplace® for Sixth Consecutive Year
Recognition follows a year focused on frontline colleaguesDELAWARE, Ohio, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a global...
OKYO Pharma to Present at the Stifel 2026 Healthcare Conference
LONDON and NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing inve...
VisionWave Targets Dual-Use Expansion Across Defense, Infrastructure, Agriculture and Aviation Markets
Company Seeks to Extend Autonomous Platforms, AI and Sensing Technologies Beyond Defense Through Shared Technology ArchitectureWEST HOLLYWOOD, Calif.,...
Cartesian Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Phase 3 AURORA trial of Descartes-08 in myasthenia gravis (MG) advances towards data readout expected in 1Q27 and biologics license application (BLA)...
Planning to Enroll at National University? How Financial Aid Timing Works and Steps to Take Before Classes Start
New National University (NU) students can file the Free Application for Federal Student Aid (FAFSA) and complete requested documents before their firs...
Beamr Featured in The Wall Street Transcript; Expects Approximately 50% Revenue Growth in 2026
In the interview, CEO Sharon Carmel highlights the commercial progress and physical AI opportunity. Beamr to engage with customers and partners at AWS...
Kayak Therapeutics Announces IND Clearance for KT-300, a Potential First-in-Class TRIM7 Inhibitor for RAS-Driven Cancers
KT-300 is a novel, oral small-molecule inhibitor of TRIM7 designed to target RAS-driven cancers independent of the underlying RAS mutationKT-300 is de...
Labrador Gold Announces Commencement of Strategic Review
TORONTO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V: LAB | FNR: 2N6) (“LabGold” or the “Company”) announces that its Board of Direc...
Opus Genetics Completes Dosing in Cohort 2 of Phase 1/2 Clinical Trial of OPGx-BEST1 Gene Therapy for Inherited Retinal Diseases
Topline three-month data from Cohort 2 expected in the first quarter of 2027, with potential pivotal Phase 3 trial dosing anticipated in the second ha...
HydroGraph to Showcase Graphene-Carbon Black Hybrid for Cost-Effective Conductive Compounds at AMI Plastics World Expo
Presentation Highlights How Low Concentrations of HydroGraph’s Fractal Graphene™ Can Reduce Electrical Resistivity by Up to 110 Times and Conductive F...